You are here: Industry Insights > COVID-19

News List

DCGI nod for Jubilant’s generic remdesivir under brand name JUBI-R expresspharma
July 21, 2020
The company will distribute the drug in the Indian market through its distribution network and will be available by the first week of August 2020.
OPKO Health's BioReference Laboratories Awarded Commercial Surge Capacity Testing for COVID-19 Emergency Response Contract by Centers for Disease Control and Prevention (CDC) prnewswire
July 21, 2020
BioReference Laboratories, Inc., an OPKO Health company, announced it will accept an Indefinite Delivery Indefinite Quantity (IDIQ) contract award to provide Commercial Surge Capacity Testing for COVID-19 Emergency Response to the CDC.
BioAegis Therapeutics receives approval to proceed with phase 2 trial of its gelsolin Covid-19 treatment pharmaceutical-business-review
July 21, 2020
BioAegis Therapeutics Inc., announces that it received regulatory clearance from The Spanish Agency for Medicines and Health Products (AEMPS) for its Phase 2 Proof of Concept study of its lead product, recombinant human plasma gelsolin (rhu-pGSN) in ...
Celltrion begins Covid-19 human clinical trial with antiviral antibody treatment pharmaceutical-business-review
July 21, 2020
Celltrion Group has commenced phase 1 human clinical study to assess the potential of its antiviral antibody treatment for patients with Covid-19.
Beroni Group to Supply COVID-19 Antibody Test Kit to Japan americanpharmaceuticalreview
July 21, 2020
Beroni Group is collaborating with Forsitech and Standard Capital to supply its SARS-CoV-2 total antibody detection kit for clinical testing in the Japanese market.
Inhaled interferon beta therapy shows promise in COVID-19 trial europeanpharmaceuticalreview
July 21, 2020
SNG001 diminished the risk of COVID-19 patients developing severe symptoms, reduced breathlessness and improved recovery rates.
Reimbursement of telemedicine services could continue even after the abatement of COVID-19 pandemic: Poll pharmaceutical-technology
July 21, 2020
Telemedicine services are being adopted widely by healthcare providers during the COVID-19 pandemic to continue providing services and avoid further surge in infection rate.
DCGI queries pharma company on its claim of FabiFlu use for COVID-19 patients with comorbidities expresspharma
July 21, 2020
As per statement by the Glenmark and media reports, the DCGI had accelerated the process for clinical trials and reviews considering the pandemic situation, unmet medical conditions and unavailability of specific therapeutic management against COVID-19...
Mylan commences supply of remdesivir in India under brand name DESREM expresspharma
July 21, 2020
Mylan announced the commercial launch of its remdesivir under the brand name DESREM for COVID-19 treatment in India. It will manufacture DESREM in its injectable facility in Bangalore.
Remdesivir treatment gains popularity in India, black marketing and price cuts to continue: GlobalData expresspharma
July 21, 2020
According to figures compiled by the CDSCO, India will be producing 20,000 vials per day by the end of July.